FDA Approves New Immunotherapy for Metastatic Melanoma FDA announced today its approval of a new immunotherapy for advanced melanoma, the deadliest and most difficult-to-treat... marzo 25, 2011julio 13, 2022
New Perspectives on Cancer and the Immune System In a new article published in Science, three CRI scientists describe how advances in the field of... marzo 25, 2011julio 13, 2022
Cancer Research Institute Announces Second Investment from Its Cancer Vaccine Acceleration Fund to Enable Manufacture of Powerful Immune Stimulant CRI's Cancer Vaccine Acceleration Fund (CVAF) has completed a new investment agreement with biotech Oncovir to enable... enero 21, 2011julio 13, 2022
Launch of Cancer Vaccine Acceleration Fund New model of venture philanthropy aims to improve cancer patient care sooner by speeding development of highly... diciembre 14, 2010julio 13, 2022
Improving Endpoints for Cancer Immunotherapy Clinical Trials The Cancer Research Institute Cancer Immunotherapy Consortium, the leading global initiative in advancing the emerging field of... septiembre 23, 2010julio 13, 2022
2010 William B. Coley Award Winners to be Honored at CRI’s 24th Annual Awards Dinner in NYC CRI announced today the three winners of the 2010 William B. Coley Award for Distinguished Research in... junio 7, 2010julio 13, 2022
